recurrence

You have access
Efficacy of Adjuvant Chemotherapy Following Curative Resection of Colorectal Cancer Liver Metastases
KAZUHISA TAKEDA, YUTARO KIKUCHI, YU SAWADA, TAKAFUMI KUMAMOTO, JUN WATANABE, CHIKARA KUNISKI, TOSHIHIRO MISUMI and ITARU ENDO

Anticancer Research November 2022, 42 (11) 5497-5505; DOI: https://doi.org/10.21873/anticanres.16055
You have access
Thyroglobulin Levels as a Predictor of Papillary Cancer Recurrence After Thyroid Lobectomy
JIN-SEONG CHO and HEE KYUNG KIM

Anticancer Research November 2022, 42 (11) 5619-5627; DOI: https://doi.org/10.21873/anticanres.16070
Open Access
Surgical Indications for Huge Hepatocellular Carcinoma
TAKAFUMI KUMAMOTO, RYUSEI MATSUYAMA, KAZUHISA TAKEDA, YU SAWADA, KOTA SAHARA, DAISUKE MORIOKA, SHAO-CIAO LUO, YASUHIRO YABUSHITA, YUKI HOMMA and ITARU ENDO

Anticancer Research May 2022, 42 (5) 2573-2581; DOI: https://doi.org/10.21873/anticanres.15735
You have access
Response to Chemotherapy and Clinical Outcome of Patients With Recurrent Epithelial Ovarian Cancer After PARP Inhibitor Maintenance Treatment: A Multicenter Retrospective Italian Study
ANGIOLO GADDUCCI, STEFANIA COSIO, FABIO LANDONI, ANDREA ALBERTO LISSONI, PAOLO ZOLA, MARIA ELENA LAUDANI, ANTONIO ARDIZZOIA, ANGELA GAMBINO and ENRICO SARTORI

Anticancer Research April 2022, 42 (4) 2017-2022; DOI: https://doi.org/10.21873/anticanres.15681
Open Access
First American Cancer Patient to Receive Dicycloplatin (DCP) Chemotherapy Achieves Remission After Seven Weeks of DCP Capsules – A Case Report
MOHAMAD W. SALKINI, XUQING YANG, FAYYAZ HAIDER HASHMI, STANLEY J. KANDZARI, THOMAS HOGAN, CHAD MORLEY, DAVID ZEKAN, ZACHARY WERNER, DORIAN J. WILLIAMS, YI GUO, THOMAS LEWIS MATTHEW, MICHAEL SPANGLER and JING JIE YU

Anticancer Research March 2022, 42 (3) 1339-1344; DOI: https://doi.org/10.21873/anticanres.15602
You have access
Prognostic and Clinicopathological Significance of Lymph Node Metastasis in the Esophagogastric Junction Adenocarcinoma
NAOKI URAKAWA, SHINGO KANAJI, SATOSHI SUZUKI, RYUICHIRO SAWADA, HITOSHI HARADA, HIRONOBU GOTO, HIROSHI HASEGAWA, KIMIHIRO YAMASHITA, TAKERU MATSUDA, TARO OSHIKIRI and YOSHIHIRO KAKEJI

Anticancer Research February 2022, 42 (2) 1051-1057; DOI: https://doi.org/10.21873/anticanres.15566
You have access
Differences in the Therapeutic Effect of Chemotherapy Regimens for Concurrent Chemoradiotherapy of Locally Advanced Non-small Cell Lung Cancer
MINORU HORIUCHI, TETSUYA OGURI, YUSUKE KAGAWA, KAZUKI SONE, SATOSHI FUKUDA, TAKEHIRO UEMURA, OSAMU TAKAKUWA, KEN MAENO, KENNSUKE FUKUMITSU, YOSHIHIRO KANEMITSU, TOMOKO TAJIRI, HIROTSUGU OHKUBO, MASAYA TAKEMURA, YUTAKA ITO and AKIO NIIMI

Anticancer Research February 2022, 42 (2) 1073-1079; DOI: https://doi.org/10.21873/anticanres.15569
You have access
Consideration of the Optimal Surgical Procedure Based on the Risk of Recurrence in Clinical Stage 0 or IA Lung Adenocarcinoma
TOMOYOSHI TAKENAKA, TETSUZO TAGAWA, MIKIHIRO KOHNO, NAOKI HARATAKE, FUMIHIKO KINOSHITA, YUKI ONO, SHO WAKASU, YUKA OKU and MASAKI MORI

Anticancer Research February 2022, 42 (2) 1137-1142; DOI: https://doi.org/10.21873/anticanres.15577
You have access
Efficacy and Safety of Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Living Donor Liver Transplantation: A Report of Two Cases
AKIHIKO ICHIDA, NOBUHISA AKAMATSU, RIHITO NAGATA, YUICHIRO MIHARA, YOSHIKUNI KAWAGUCHI, SUNG KWAN BAE, TAKEAKI ISHIZAWA, JUNICHI KANEKO, JUNICHI ARITA and KIYOSHI HASEGAWA

Anticancer Research February 2022, 42 (2) 1161-1167; DOI: https://doi.org/10.21873/anticanres.15581
You have access
A Novel Prediction Model for Colon Cancer Recurrence Using Auto-artificial Intelligence
JUNICHI MAZAKI, KENJI KATSUMATA, YUKI OHNO, RYUTARO UDO, TOMOYA TAGO, KENTA KASAHARA, HIROSHI KUWABARA, MASANOBU ENOMOTO, TETSUO ISHIZAKI, YUICHI NAGAKAWA and AKIHIKO TSUCHIDA

Anticancer Research September 2021, 41 (9) 4629-4636; DOI: https://doi.org/10.21873/anticanres.15276

Main menu

User menu

Search

recurrence

Pages